Ray Sumita bought CUE
August 13, 2026 · Form 4 insider transaction
Ray Sumita bought 18,196 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,196
Price
$0.00
Total value
N/A
InsiderRay Sumita
RoleOfficer, Director
CompanyCue Biopharma, Inc. (CUE)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 13, 2026
Filing dateAugust 17, 2026
Shares owned after127,374
OwnershipDirect
10b5-1 planNo
AmendedNo